- Trials with a EudraCT protocol (252)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
252 result(s) found for: Modulation.
Displaying page 1 of 13.
EudraCT Number: 2013-002143-29 | Sponsor Protocol Number: 10378/13 | Start Date*: 2013-08-03 |
Sponsor Name:POLICLINICO GEMELLI | ||
Full Title: Pharmacological modulation of inflammation and platelet activation in inflammatory bowel diseases | ||
Medical condition: | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002481-78 | Sponsor Protocol Number: EBI-EA230-LPS-2014 | Start Date*: 2014-10-07 |
Sponsor Name:Exponential Biotherapies Inc | ||
Full Title: Randomized double blind placebo-controlled clinical safety, tolerability and pharmacokinetic/-dynamic study on the effects of escalating single intravenous doses of EA-230 on the innate immune resp... | ||
Medical condition: Systemic inflammatory respons (SIRS) and associated acute kidney injury (AKI) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-006302-28 | Sponsor Protocol Number: OXYGENE | Start Date*: 2012-07-11 |
Sponsor Name:UNIVERSITA' DEGLI STUDI DI PARMA | ||
Full Title: Dopamine modulation of oxytocin prosocial effects | ||
Medical condition: HEALTHY VOLUNTEERS. FOR PATIENTS WITH AUTISM OR SCHIZOPHRENIA | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005383-42 | Sponsor Protocol Number: BREATH | Start Date*: 2016-05-19 | ||||||||||||||||
Sponsor Name:FONDAZIONE TOSCANA GABRIELE MONASTERIO | ||||||||||||||||||
Full Title: Use of buspiron in chemioreflex modulation and central apnea treatment in heart failure patients (BREATH: BuspiRon for chEmoreflex modulation and central Apnea treatment in Heart failure patients).... | ||||||||||||||||||
Medical condition: patient with central apneas syndrome and heart failure | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-001285-11 | Sponsor Protocol Number: P20.XXX | Start Date*: 2021-01-12 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: A Randomized, open label, Non-inferiority trial on the efficacy of Lacosamide versus Duloxetine in Patients with Chemotherapy-induced Polyneuropathy – A strategy trial | ||
Medical condition: Chemotherapy-induced polyneuropathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005701-20 | Sponsor Protocol Number: ANST2015_1 | Start Date*: 2015-05-20 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Shifting pain modulation towards anti-nociceptivity: Mechanism-specific pharmacological prevention of post sternotomy pain: the MASTER study | ||
Medical condition: chronic pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-003574-26 | Sponsor Protocol Number: ucihsjd5 | Start Date*: 2008-04-09 |
Sponsor Name:Hospital Sant Joan de Deu | ||
Full Title: MODULACIÓN DE LA RESPUESTA INFLAMATORIA SISTÉMICA EN NIÑOS CRÍTICAMENTE ENFERMOS TRAS LA SUPLEMENTACIÓN CON GLUTAMINA MODULATION OF THE SYSTEMIC INFLAMMATORY RESPONSE IN CRITICAL ILL CHILDREN AFTE... | ||
Medical condition: MODULACIÓN DE LA RESPUESTA INFLAMATORIA SISTÉMICA EN NIÑOS CRÍTICAMENTE ENFERMOS TRAS LA SUPLEMENTACIÓN CON GLUTAMINA MODULATION OF THE SYSTEMIC INFLAMMATORY RESPONSE IN CRITICAL ILL CHILDREN AFTE... | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000434-21 | Sponsor Protocol Number: LP1 | Start Date*: 2005-06-15 |
Sponsor Name:Kognitive Neurologie, Institut für Medizin, Forschungszentrum Jülich | ||
Full Title: Neurochemische Modulation von Exekutiv- und Gedächtnisfunktionen | ||
Medical condition: Progressive cognitive decline in physiological aging | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004208-37 | Sponsor Protocol Number: S63190 | Start Date*: 2020-08-03 |
Sponsor Name:UZ Leuven | ||
Full Title: Drug repurposing - Statins as microbiota modulating agents in ulcerative colitis | ||
Medical condition: There are two population groups, 20 healthy volunteers and at least 165 individuals diagnosed with IBD. Either with remission to mild/moderate active ulcerative colitis or remission to mild Crohn's... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001212-30 | Sponsor Protocol Number: GW/MB/42964 | Start Date*: 2013-07-04 |
Sponsor Name: | ||
Full Title: Modulation of immune function by parenteral fish oil in patients with Crohn’s disease and high inherent Tumor Necrosis Factor-alfa production, a randomized, single blinded, cross-over study | ||
Medical condition: Crohn's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003617-33 | Sponsor Protocol Number: 03-2005 | Start Date*: Information not available in EudraCT |
Sponsor Name:Charité | ||
Full Title: A Randomised Cross-Over Study to Explore the Pathophysiological Mechanisms Involved in the Treatment of Actinic Keratoses with Solaraze | ||
Medical condition: actinic keratosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-004372-39 | Sponsor Protocol Number: SKS-HIV-002 | Start Date*: 2007-11-05 |
Sponsor Name:Department of Infectious Diseases, Aarhus University Hospital, Skejby | ||
Full Title: Effect and safety of switching from zidovudin to either tenofovir or abacavir in patients suffering from HIV. An open label study. | ||
Medical condition: HIV | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023044-32 | Sponsor Protocol Number: DCS-fMRIPanik | Start Date*: 2011-08-10 |
Sponsor Name:Charité Universitaetsmedizin Berlin | ||
Full Title: Mechanisms of action in exposure therapy: Decoding the neural basis of fear extinction and its pharmacological modulation in patients with panic disorder | ||
Medical condition: panic disorder and agoraphobia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-004066-32 | Sponsor Protocol Number: OB/ERYTH 2004-004066-32 | Start Date*: 2006-02-01 |
Sponsor Name:Silvia Delgado Aros | ||
Full Title: Reducción de la Ingesta Calórica en la Obesidad Mediante Modulación Farmacológica del Vaciamiento Gástrico Reduction of Caloric Intake in Obesity through Pharmacological Modulation of Gastric Empt... | ||
Medical condition: Obesidad/Sobrepeso Obesity/Overweight | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-000397-59 | Sponsor Protocol Number: none | Start Date*: 2011-03-21 |
Sponsor Name: | ||
Full Title: Prevention of post-ERCP acute pancreatitis by heme-oxygenase activation through the administration of hemin: a prospective, randomized double blind controlled trial. | ||
Medical condition: Prevention of post-ERCP acute pancreatitis. So, patient with indications of ERCP (endoscopic retrograde cholangiopanreatography) will be included. These patients suffer from bilio-pancreatic disord... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000024-34 | Sponsor Protocol Number: CH-MAX-FACC-TR-12 | Start Date*: 2015-01-13 | |||||||||||
Sponsor Name:AOU di Bologna, Policlinico S.Orsola-Malpighi | |||||||||||||
Full Title: Use of PRP from umbilical cord in post-extractive sites | |||||||||||||
Medical condition: • Patients who require extraction of dental elements and subsequent implant rehabilitation in the same site. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001970-28 | Sponsor Protocol Number: CMV-001 | Start Date*: 2012-11-20 | ||||||||||||||||
Sponsor Name:University of Birmingham | ||||||||||||||||||
Full Title: Does CMV reactivation cause functional impairment of CMV specific CD4+ T-cells? The potential for valaciclovir to prevent CMV-mediated adverse modulation of the immune system in patients with ANCA-... | ||||||||||||||||||
Medical condition: This study will investigate the modulation of the immune system by Cytomegalovirus (CMV) in ANCA-associated vasculitis. Specifically the study will investigate the potential for valaciclovir to ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000408-16 | Sponsor Protocol Number: HS-PM-013 | Start Date*: 2005-04-05 |
Sponsor Name:Karolinska University Hospital, Huddinge | ||
Full Title: Caffeine-mediated modulation of human experimental pain models | ||
Medical condition: Healthy human volunteer subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-003822-80 | Sponsor Protocol Number: 04/035 | Start Date*: 2005-01-12 |
Sponsor Name:The Leeds Teaching Hospitals NHS Trust | ||
Full Title: Modulation of Sympathetic Nerve Activity By Pioglitazone In Type 2 Diabetes Mellitus | ||
Medical condition: Type 2 diabetes mellitus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2008-006776-29 | Sponsor Protocol Number: 081016 | Start Date*: 2009-02-18 |
Sponsor Name:Karolinska Institutet | ||
Full Title: NO som behandling vid knäproteskirurgi. Studie med avseende på anti-inflammatorisk modulation hos patienter som genomgår operation med ryggbedövning. | ||
Medical condition: Patienter som skall genomgå knäprotesoperation och skall ha bedövning i form av ryggbedövning (spinalanestes/epiduralanestesi). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
